LYPD3 and head and neck squamous cell carcinoma: Furthermore, our clinical data unveil a significant association between elevated levels of miR-151-5p and reduced levels of LYPD3 with unfavorable prognosis in HNSCC patients, underscoring their potential as valuable prognostic biomarkers and promising therapeutic targets.